Kocher Olivier, Krieger Monty
Department of Pathology, Beth Israel-Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA.
Curr Opin Lipidol. 2009 Jun;20(3):236-41. doi: 10.1097/MOL.0b013e32832aee82.
Regulation of lipoprotein receptor activity influences lipoprotein metabolism, related physiology and pathophysiology. Adaptor proteins that bind to the LDL or HDL receptors apparently link these receptors to cellular components essential for their normal functioning. Here, we focus on the influence of PDZK1 on the HDL receptor scavenger receptor class B type I (SR-BI), with emphasis on the roles played by its individual PDZ domains, the impact in regulating HDL metabolism and the relevance for cardiovascular disease.
PDZK1 plays an essential role in maintaining hepatic SR-BI levels and controlling HDL metabolism, protects against the development of atherosclerosis in a murine model and also mediates SR-BI-dependent regulation of endothelial cell biology by HDL, suggesting that PDZK1 plays multiple roles in normal physiology and may influence associated disorder. All four PDZ domains of PDZK1 appear necessary to promote normal hepatic expression, function and intracellular localization of SR-BI.
SR-BI mediates several features of HDL metabolism and function, some of which depend on SR-BI's interaction with PDZK1. Exploration of the structure and function of PDZK1 and the mechanisms by which it controls SR-BI will provide additional insights into HDL metabolism and may provide the basis for new therapeutic modalities for cardiovascular disease.
脂蛋白受体活性的调节影响脂蛋白代谢、相关生理学和病理生理学。与低密度脂蛋白(LDL)或高密度脂蛋白(HDL)受体结合的衔接蛋白显然将这些受体与正常功能所必需的细胞成分联系起来。在这里,我们重点关注PDZK1对HDL受体B类I型清道夫受体(SR-BI)的影响,重点在于其各个PDZ结构域所起的作用、对HDL代谢调节的影响以及与心血管疾病的相关性。
PDZK1在维持肝脏SR-BI水平和控制HDL代谢中起关键作用,在小鼠模型中可预防动脉粥样硬化的发展,还介导HDL对内皮细胞生物学的SR-BI依赖性调节,这表明PDZK1在正常生理学中发挥多种作用,并可能影响相关疾病。PDZK1的所有四个PDZ结构域似乎都是促进SR-BI正常肝脏表达、功能和细胞内定位所必需的。
SR-BI介导HDL代谢和功能的几个特征,其中一些取决于SR-BI与PDZK1的相互作用。对PDZK1的结构和功能及其控制SR-BI的机制进行探索,将为HDL代谢提供更多见解,并可能为心血管疾病的新治疗模式提供基础。